ACT Genomics Co. Ltd. (Hong Kong) offers a RUO ACTOnco + kit that covers 440 genes with the glioma-related ones (IDH1, IDH2, BRAF, CDKN2A, CDKN2B, CIC, FUBP1, NOTCH1, etc.)for solid tumor molecular profiling compatible with the Ion Torrent platform (Jan et al., 2022). This evidence concerns the gene BRAF and central nervous system cancer.